Despite involvement of TYK2 in fusion proteins and the presence of activating mutations in some cancers, with the exception of T-ALL [3, 10], little is known regarding TYK2’s oncogenic functions and downstream effectors. Here, TYK2 is linked to acute lymphoblastic leukemia.